Campbell David Alan 4
4 · Janux Therapeutics, Inc. · Filed Dec 3, 2024
Insider Transaction Report
Form 4
Campbell David Alan
DirectorPresident and CEO
Transactions
- Sale
Common Stock
2024-12-03$67.00/sh−15,000$1,005,000→ 242,054 total
Footnotes (1)
- [F1]The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 21, 2024.